Frank Behrens

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 37

Top Topics

Rheumatoid Arthritis

Top Venues

Rheumatology and therapy

Journal of clinical medicine

Npj mental health research

This page only lists publications with an associated author ORCID identifier.

Publications

Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Lars Erik Kristensen, Mauro Keiserman, Kim A Papp, Leslie McCasland, Douglas White, Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Ahmed M Soliman, Michael Chen, Byron Padilla, Frank Behrens
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial. Rheumatology and therapy 11 (3) (2024)
Lars Erik Kristensen, Mauro Keiserman, Kim A Papp, Leslie McCasland, Douglas White, Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Ahmed M Soliman, Michael Chen, Byron Padilla, Frank Behrens
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial. Rheumatology and therapy 11 (3) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Linda T Betz, Gitta A Jacob, Johannes Knitza, Michaela Köhm, Frank Behrens
Efficacy of a cognitive-behavioral digital therapeutic on psychosocial outcomes in rheumatoid arthritis: randomized controlled trial. Npj mental health research 3 (1) (2024)
Linda T Betz, Gitta A Jacob, Johannes Knitza, Michaela Köhm, Frank Behrens
Efficacy of a cognitive-behavioral digital therapeutic on psychosocial outcomes in rheumatoid arthritis: randomized controlled trial. Npj mental health research 3 (1) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Lars Erik Kristensen, Mauro Keiserman, Kim A Papp, Leslie McCasland, Douglas White, Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Ahmed M Soliman, Michael Chen, Byron Padilla, Frank Behrens
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial. Rheumatology and therapy (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Lars Erik Kristensen, Mauro Keiserman, Kim A Papp, Leslie McCasland, Douglas White, Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Ahmed M Soliman, Michael Chen, Byron Padilla, Frank Behrens
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial. Rheumatology and therapy 11 (3) (2024)
Lars Erik Kristensen, Mauro Keiserman, Kim A Papp, Leslie McCasland, Douglas White, Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Ahmed M Soliman, Michael Chen, Byron Padilla, Frank Behrens
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial. Rheumatology and therapy 11 (3) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy (2023)
Matthias Augustin, Lisa Lindner, Laura Kühl, Anja Weiß, Stephan Jeff Rustenbach, Brigitte Stephan, Martin Feuchtenberger, Ulrich Mrowietz, Diamant Thaçi, Petra Staubach, Xenofon Baraliakos, Anja Strangfeld, Ralph von Kiedrowski, Frank Behrens, Anne Constanze Regierer
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2023)
Michaela Köhm, Frank Behrens
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: limitations and opportunities. RMD open 9 (3) (2023)
Anne Constanze Regierer, Anja Weiß, Fabian Proft, Xenofon Baraliakos, Frank Behrens, Denis Poddubnyy, Georg Schett, Hanns-Martin Lorenz, Matthias Worsch, Anja Strangfeld
Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA. RMD open 9 (1) (2023)
Michaela Köhm, Sarah Ohrndorf, Ann C Foldenauer, Tanja Rossmanith, Marina Backhaus, Stephanie G Werner, Gerd-Rüdiger R Burmester, Siegfried Wassenberg, Benjamin Koehler, Harald Burkhardt, Frank Behrens
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up. RMD open 8 (2) (2023)
Matthias Augustin, Lisa Lindner, Laura Kühl, Anja Weiß, Stephan Jeff Rustenbach, Brigitte Stephan, Martin Feuchtenberger, Ulrich Mrowietz, Diamant Thaçi, Petra Staubach, Xenofon Baraliakos, Anja Strangfeld, Ralph von Kiedrowski, Frank Behrens, Anne Constanze Regierer
Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern: Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 21 (10) (2023)
Beverly Cheok Kuan Ng, Deepak R Jadon, Frank Behrens, Maarten P T de Wit, Oliver M FitzGerald, Dafna D Gladman, Phillip J Mease, Denis O'Sullivan, Stephen R Pennington, Larissa Valor-Méndez, Vinod Chandran, Kurt de Vlam
Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. The Journal of rheumatology (2023)
Michaela Koehm, Maximilian Klippstein, Stephanie Dauth, Konstantin Hallmann, Niko Kohmer, Harald Burkhardt, Sandra Ciesek, Gerd Geisslinger, Holger F Rabenau, Frank Behrens
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study. RMD open 9 (3) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Michaela Köhm, Sarah Ohrndorf, Ann C Foldenauer, Tanja Rossmanith, Marina Backhaus, Stephanie G Werner, Gerd-Rüdiger R Burmester, Siegfried Wassenberg, Benjamin Koehler, Harald Burkhardt, Frank Behrens
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up. RMD open 8 (2) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Michaela Köhm, Sarah Ohrndorf, Ann C Foldenauer, Tanja Rossmanith, Marina Backhaus, Stephanie G Werner, Gerd-Rüdiger R Burmester, Siegfried Wassenberg, Benjamin Koehler, Harald Burkhardt, Frank Behrens
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up. RMD open 8 (2) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Rieke Alten, Martin Aringer, Marina Backhaus, Gerd R Burmester, Eugen Feist, Herbert Kellner, Klaus Krueger, Ulf Müller-Ladner, Andrea Rubbert-Roth, Hans-Peter Tony, Siegfried Wassenberg, Harald Burkhardt, Frank Behrens
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of clinical medicine 11 (24) (2022)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Rieke Alten, Martin Aringer, Marina Backhaus, Gerd R Burmester, Eugen Feist, Herbert Kellner, Klaus Krueger, Ulf Müller-Ladner, Andrea Rubbert-Roth, Hans-Peter Tony, Siegfried Wassenberg, Harald Burkhardt, Frank Behrens
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of clinical medicine 11 (24) (2022)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy 9 (2) (2022)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Rieke Alten, Martin Aringer, Marina Backhaus, Gerd R Burmester, Eugen Feist, Herbert Kellner, Klaus Krueger, Ulf Müller-Ladner, Andrea Rubbert-Roth, Hans-Peter Tony, Siegfried Wassenberg, Harald Burkhardt, Frank Behrens
Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA). Journal of clinical medicine 11 (24) (2022)
Frank Behrens, Philipp Sewerin, Eugenio de Miguel, Yusuf Patel, Anastas Batalov, Eva Dokoupilova, Christine Kleinmond, Effie Pournara, Ankita Shekhawat, Claudia Jentzsch, Annette Wiedon, Xenofon Baraliakos, null null
Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: Results from a Phase 3b trial. Rheumatology (Oxford, England) (2021)
Frank Behrens, Michaela Koehm, Tanja Rossmanith, Rieke E Alten, Martin Aringer, Marina Backhaus, Gerd R Burmester, Eugen Feist, Eva Herrmann, Herbert Kellner, Klaus Krueger, Annette Lehn, Ulf Müller-Ladner, Andrea Rubbert-Roth, Hans-Peter Tony, Siegfried Wassenberg, Harald Burkhardt
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study). Rheumatology (Oxford, England) 60 (11) (2021)
Frank Behrens, Soyi Liu Leage, Christophe Sapin, Celine El Baou, Inmaculada De La Torre, Gabriella Meszaros, Larissa Valor-Méndez, Bernard G Combe, Filip E Van den Bosch, Laure Gossec
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52. Clinical rheumatology 40 (12) (2021)